Ainos extends patent license with TCNT for three months at $95k/month

Ainos, Inc.

Second Addendum extends non-exclusive patent use for VOC/POCT tech from July to Sept 2024.
Monthly fee of US$95,000 plus 5% sales tax for the three-month extension.
Co-development fee of NT$5 million (≈USD$161,000) paid for five-year period starting 2024.
TCNT holds ~39% voting power of Ainos via a Cayman entity; related party transaction.
Scope includes VOC diagnostics, AI Nose, POCT, VELDONA drug processing, and more.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.